Private Brisbane biotech VasCam has begun animal trials of a technology that would allow heart-bypass patients, or patients with blocked leg arteries, to grow their own replacement blood vessels.
Private Brisbane biotech VasCam has begun animal trials of a technology that would allow heart-bypass patients, or patients with blocked leg arteries, to grow their own replacement blood vessels.
